Guangxu Jin

3.4k total citations
51 papers, 2.2k citations indexed

About

Guangxu Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guangxu Jin has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Immunology. Recurrent topics in Guangxu Jin's work include Bioinformatics and Genomic Networks (11 papers), Computational Drug Discovery Methods (8 papers) and Immune Cell Function and Interaction (6 papers). Guangxu Jin is often cited by papers focused on Bioinformatics and Genomic Networks (11 papers), Computational Drug Discovery Methods (8 papers) and Immune Cell Function and Interaction (6 papers). Guangxu Jin collaborates with scholars based in United States, China and Japan. Guangxu Jin's co-authors include Stephen T.C. Wong, Luonan Chen, Hong Zhao, Yong Lu, Gang Xue, Jing Fang, Shihua Zhang, Kounosuke Watabe, Kemi Cui and Hui‐Wen Lo and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Bioinformatics.

In The Last Decade

Guangxu Jin

47 papers receiving 2.2k citations

Peers

Countries citing papers authored by Guangxu Jin

Since Specialization

Citations

This map shows the geographic impact of Guangxu Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangxu Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangxu Jin more than expected).

Fields of papers citing papers by Guangxu Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangxu Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangxu Jin. The network helps show where Guangxu Jin may publish in the future.

Co-authorship network of co-authors of Guangxu Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Guangxu Jin. A scholar is included among the top collaborators of Guangxu Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangxu Jin. Guangxu Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coupling the recycling of spent carbide slag and the conversion of low-rank coal for the production of hydrogen-rich syngas 2025 ·Journal of the Energy Institute ·(unknown), Guangxu Jin, Xiao Zhang, Yanpeng Ban, Qingfu Zhang, Keduan Zhi	1
2	Immunophenotyping of Synovial Tissue in Adolescents Undergoing ACL Reconstruction: What Is the Role of Synovial Inflammation in Arthrofibrosis? 2025 ·The American Journal of Sports Medicine ·Sarah M. Romereim, (unknown), (unknown), Elise C. Carey, (unknown), (unknown), (unknown), (unknown), (unknown), Ziqing Yu, Guangxu Jin, (unknown), (unknown), Susan M. Odum, Bailey V. Fearing, (unknown)	1
3	Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases 2022 ·Cancer Letters ·Sherona Sirkisoon, Grace L. Wong, (unknown), Daniel Doheny, Dongqin Zhu, Angelina T. Regua, (unknown), Sara G. Manore, (unknown), Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui‐Wen Lo	38
4	NEDD4 degrades TUSC2 to promote glioblastoma progression 2022 ·Cancer Letters ·Tadas Rimkus, (unknown), Dongqin Zhu, Richard L. Carpenter, Sherona Sirkisoon, Daniel Doheny, Angelina T. Regua, Grace L. Wong, Sara G. Manore, (unknown), Hui‐Kuan Lin, Guangxu Jin, Jimmy Ruiz, Michael D. Chan, Waldemar Debinski, Hui‐Wen Lo	9
5	Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance 2022 ·Cancer Cell ·Ningbo Zheng, Jing Fang, Gang Xue, Ziyu Wang, Xiaoyin Li, (unknown), Guangxu Jin, Masmudur M. Rahman, Grant McFadden, (unknown)	58
6	Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells 2021 ·Nature Biomedical Engineering ·Gang Xue, Ziyu Wang, Ningbo Zheng, Jing Fang, Chengqiong Mao, Xiaoyin Li, Guangxu Jin, Xin Ming, Yong Lu	35
7	Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes 2021 ·Frontiers in Oncology ·Ashok Pullikuth, Eric D. Routh, Kip D. Zimmerman, Julia Chifman, Jeff W. Chou, M. Soike, Guangxu Jin, Jing Su, Qianqian Song, Michael A. Black, Cristin G. Print, Davide Bedognetti, Marissa Howard-McNatt, Stacey S. O’Neill, Alexandra Thomas, Carl D. Langefeld, Alexander B. Sigalov, Yong Lu, Lance D. Miller	22
8	Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy 2020 ·Annals of Surgical Oncology ·Jing Su, Guangxu Jin, Konstantinos I. Votanopoulos, (unknown), Perry Shen, Jeff W. Chou, Shadi Qasem, Stacey S. O’Neill, Kathleen C. Perry, Lance D. Miller, Edward A. Levine	15
9	IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling 2019 ·Nature Communications ·Gang Xue, Guangxu Jin, Jing Fang, Yong Lu	81
10	A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia 2018 ·Clinical Cancer Research ·Timothy S. Pardee, Rebecca G. Anderson, (unknown), Scott Isom, (unknown), Lance D. Miller, Jeff W. Chou, Guangxu Jin, Wei Zhang, Leslie R. Ellis, Dmitriy Berenzon, Dianna S. Howard, David D. Hurd, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell	80
11	Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis 2018 ·Cancer Research ·Fei Xing, Yin Liu, Shih-Ying Wu, Kerui Wu, Sambad Sharma, Yin‐Yuan Mo, Jiamei Feng, Stephanie Sanders, Guangxu Jin, Ravi Singh, Pierre‐Alexandre Vidi, Abhishek Tyagi, Michael D. Chan, Jimmy Ruiz, Waldemar Debinski, Boris Pasche, Hui‐Wen Lo, Linda J. Metheny‐Barlow, Ralph B. D’Agostino, Kounosuke Watabe	259
12	Tumor mutational burden is a determinant of immune-mediated survival in breast cancer 2018 ·OncoImmunology ·Alexandra Thomas, Eric D. Routh, Ashok Pullikuth, Guangxu Jin, Jing Su, Jeff W. Chou, Katherine A. Hoadley, Cristin G. Print, Nicholas Knowlton, Michael A. Black, Sandra Demaria, Ena Wang, Davide Bedognetti, Wendell Jones, Gaurav Mehta, Michael L. Gatza, Charles M. Perou, David B. Page, Pierre L. Triozzi, Lance D. Miller	209
13	Bayesian network model for identification of pathways by integrating protein interaction with genetic interaction data 2017 ·BMC Systems Biology ·(unknown), Su Deng, Guangxu Jin, Xinxin Wang, Zu‐Guo Yu	10
14	Modeling the relationship of epigenetic modifications to transcription factor binding 2015 ·Nucleic Acids Research ·Liang Liu, Guangxu Jin, Xiaobo Zhou	77
15	Novel Modeling of Cancer Cell Signaling Pathways Enables Systematic Drug Repositioning for Distinct Breast Cancer Metastases 2013 ·Cancer Research ·Hong Zhao, Guangxu Jin, Kemi Cui, Ding Ren, Timothy Liu, Peikai Chen, (unknown), Fuhai Li, Yubo Fan, Ángel Luis Rodríguez, Jenny C. Chang, Stephen T.C. Wong	28
16	Transcriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform 2013 ·Scientific Reports ·Timothy Liu, Ding Ren, Xiaoping Zhu, Zheng Yin, Guangxu Jin, Zhen Zhao, Daniel Robinson, (unknown), Kelvin Wong, Kemi Cui, Hong Zhao, Stephen T.C. Wong	33
17	Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines 2013 ·Drug Discovery Today ·Guangxu Jin, Stephen T.C. Wong	303
18	A Novel Method of Transcriptional Response Analysis to Facilitate Drug Repositioning for Cancer Therapy 2011 ·Cancer Research ·Guangxu Jin, (unknown), Hong Zhao, Kemi Cui, Jenny C. Chang, Stephen T.C. Wong	61
19	Modeling post-transcriptional regulation activity of small non-coding RNAs in Escherichia coli 2009 ·BMC Bioinformatics ·Rui‐Sheng Wang, Guangxu Jin, (unknown), Luonan Chen	10
20	Discovering functions and revealing mechanisms at molecular level from biological networks 2007 ·PROTEOMICS ·Shihua Zhang, Guangxu Jin, Xiang‐Sun Zhang, Luonan Chen	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact